IQVIA Holdings Inc. (NYSE:IQV) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Shares of IQVIA Holdings Inc. (NYSE:IQV) have earned an average rating of “Moderate Buy” from the twenty-one research firms that are presently covering the firm, Marketbeat Ratings reports. Three analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $255.82.

IQV has been the subject of several recent research reports. The Goldman Sachs Group cut their target price on shares of IQVIA from $280.00 to $250.00 and set a “buy” rating for the company in a report on Friday, November 1st. TD Cowen decreased their price objective on shares of IQVIA from $270.00 to $255.00 and set a “buy” rating for the company in a research report on Friday, November 1st. Redburn Atlantic assumed coverage on IQVIA in a research report on Monday, October 14th. They set a “buy” rating and a $276.00 target price on the stock. Evercore ISI reduced their price target on IQVIA from $270.00 to $265.00 and set an “outperform” rating for the company in a report on Tuesday, October 8th. Finally, Robert W. Baird dropped their price objective on IQVIA from $213.00 to $212.00 and set a “neutral” rating on the stock in a report on Wednesday, December 11th.

IQVIA Stock Up 1.2 %

Shares of IQV stock opened at $197.39 on Wednesday. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 1.76. IQVIA has a twelve month low of $187.62 and a twelve month high of $261.73. The stock has a 50 day moving average of $202.86 and a 200 day moving average of $222.07. The stock has a market cap of $35.83 billion, a P/E ratio of 25.90, a P/E/G ratio of 2.05 and a beta of 1.49.

Hedge Funds Weigh In On IQVIA

Institutional investors have recently added to or reduced their stakes in the stock. FMR LLC increased its stake in shares of IQVIA by 38.7% in the 3rd quarter. FMR LLC now owns 2,887,342 shares of the medical research company’s stock worth $684,213,000 after acquiring an additional 804,963 shares during the last quarter. B. Metzler seel. Sohn & Co. Holding AG purchased a new stake in shares of IQVIA in the third quarter valued at about $147,683,000. JPMorgan Chase & Co. raised its stake in IQVIA by 46.2% during the third quarter. JPMorgan Chase & Co. now owns 1,845,711 shares of the medical research company’s stock worth $437,378,000 after purchasing an additional 583,396 shares during the period. 1832 Asset Management L.P. boosted its holdings in IQVIA by 472.3% in the 2nd quarter. 1832 Asset Management L.P. now owns 456,335 shares of the medical research company’s stock valued at $96,487,000 after purchasing an additional 376,595 shares during the last quarter. Finally, Renaissance Technologies LLC purchased a new stake in shares of IQVIA in the 2nd quarter valued at approximately $70,610,000. Hedge funds and other institutional investors own 89.62% of the company’s stock.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.